New Zealand Medical Imaging Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

New Zealand Medical Imaging Market Size

• The New Zealand medical imaging market size was valued at USD 874.94 million in 2025 and is expected to reach USD 1,342.77 million by 2033, at a CAGR of 5.5% during the forecast period
•  The market growth is largely fueled by the increasing prevalence of chronic diseases, government healthcare modernization initiatives, and rising adoption of advanced diagnostic imaging modalities such as MRI, CT, and ultrasound across hospitals and diagnostic centers
• Furthermore, technological advancements, including integration of AI in imaging workflows, digital PACS systems, and enhanced diagnostic precision, along with growing consumer demand for accurate and timely diagnostics, are establishing medical imaging solutions as critical components of New Zealand’s healthcare infrastructure

New Zealand Medical Imaging Market Analysis

• Medical imaging, including MRI, CT, X-ray, and ultrasound, is increasingly vital in New Zealand’s healthcare ecosystem, enabling accurate diagnosis, treatment planning, and monitoring of chronic and acute conditions
• The escalating demand for medical imaging is primarily fueled by the rising prevalence of chronic diseases, increasing government healthcare investments, growing awareness of early diagnosis, and the adoption of advanced imaging technologies
• Technological advancements such as AI-assisted image analysis, digital PACS systems, and cloud-based imaging solutions are enhancing diagnostic accuracy, workflow efficiency, and remote consultation capabilities, driving broader adoption across healthcare facilities
• Government initiatives aimed at modernizing healthcare infrastructure, improving access to diagnostic services, and reducing waiting times are creating favorable conditions for the expansion of the medical imaging market in New Zealand
• MRI segment dominated the New Zealand medical imaging market with a market share of 36.9% in 2025, driven by their non-invasive nature, superior imaging precision, and widespread application across neurology, oncology, and musculoskeletal diagnostics

Report Scope and New Zealand Medical Imaging Market Segmentation           

New Zealand Medical Imaging Market Trends

“Integration of AI and Advanced Imaging Analytics”

• A significant and accelerating trend in the New Zealand medical imaging market is the adoption of artificial intelligence (AI) and advanced imaging analytics across MRI, CT, and ultrasound systems, enhancing diagnostic accuracy and workflow efficiency
• For instance, AI-powered imaging software in Wellington hospitals can detect subtle anomalies in MRI scans, assisting radiologists in early disease detection and treatment planning
• AI integration enables features such as automated image segmentation, pattern recognition, and predictive analytics for patient outcomes. For instance, some Christchurch diagnostic centers use AI to flag potential tumors in CT scans, improving early diagnosis rates
• The seamless integration of AI with PACS and hospital information systems facilitates centralized management of imaging data, allowing radiologists to review, annotate, and share scans efficiently across departments
• This trend towards more intelligent, precise, and interconnected imaging solutions is transforming clinical workflows, with companies such as GE Healthcare and Philips developing AI-enabled imaging platforms capable of real-time diagnostic assistance
• The demand for AI-integrated medical imaging solutions is growing rapidly across hospitals and diagnostic centers, as healthcare providers increasingly prioritize accuracy, efficiency, and predictive capabilities in patient care
• Remote imaging and teleradiology integration is another emerging trend, enabling specialists to analyze scans from distant locations and provide timely recommendations to rural or underserved areas

New Zealand Medical Imaging Market Dynamics

Driver

“Rising Demand Due to Growing Chronic Disease Burden and Healthcare Modernization”

• The increasing prevalence of chronic diseases, coupled with government investments in healthcare infrastructure, is a significant driver for the growing adoption of advanced medical imaging solutions
• For instance, in March 2025, Auckland District Health Board announced the expansion of CT and MRI facilities in major hospitals to support early cancer detection and chronic disease management
• As healthcare providers focus on early diagnosis and precision treatment, medical imaging offers advanced capabilities such as high-resolution scans, AI-assisted interpretation, and 3D imaging to improve patient outcomes
• Furthermore, the rising emphasis on preventive healthcare and timely diagnostics is making advanced imaging an integral component of New Zealand’s clinical workflow, ensuring rapid and accurate assessments
• The convenience of faster diagnostic procedures, reduced patient wait times, and integration with hospital information systems are key factors propelling the adoption of modern imaging technologies across both hospitals and specialized diagnostic centers
• For instance, private hospital chains in Christchurch are increasingly investing in hybrid imaging systems, combining PET and CT scans to enable more comprehensive diagnostics in a single session
• The growth of medical tourism in New Zealand is also driving demand for high-quality diagnostic imaging services, as international patients seek advanced imaging capabilities before elective treatments

Restraint/Challenge

“High Equipment Costs and Skilled Workforce Shortage”

• The relatively high cost of advanced imaging equipment such as MRI and PET scanners poses a significant challenge to broader market penetration, particularly for smaller clinics or rural healthcare facilities
• For instance, smaller South Island diagnostic centers may delay upgrading imaging systems due to budget constraints, limiting access to advanced diagnostics in less populated areas
• Addressing these challenges requires investment in cost-effective solutions, leasing models, and government subsidies to support equipment acquisition and maintenance. In addition, a shortage of trained radiologists and imaging technicians can slow adoption and utilization of advanced imaging technologies
• While training programs and partnerships with universities are gradually improving workforce availability, limited skilled personnel remains a bottleneck in some regions, affecting timely diagnostics and patient care
• Overcoming these challenges through government support, workforce development, and affordable imaging solutions will be vital for sustained growth of New Zealand’s medical imaging market
• For instance, delays in updating regulatory approvals for new imaging equipment can restrict timely adoption of cutting-edge technologies in clinical settings
• The high cost of integrating AI software and maintaining cybersecurity for connected imaging devices adds another layer of financial and technical complexity for healthcare providers

New Zealand Medical Imaging Market Scope

The market is segmented on the basis of product, technology, application, modality, indication, end user, and distribution channel.

• By Product

On the basis of product, the New Zealand medical imaging market is segmented into X‑Ray, MRI, Ultrasound, CT, Nuclear Imaging, Microscopy Systems, and Others. The MRI segment dominated the New Zealand medical imaging market with a market share of 36.9% in 2025, driven by their superior imaging precision, non-invasive nature, and versatility across neurology, oncology, cardiology, and musculoskeletal diagnostics. Hospitals and advanced diagnostic centers rely heavily on MRI for early detection, staging, and monitoring of complex conditions. Technological advancements such as high-field MRI and AI-assisted image interpretation further enhance clinical confidence. Integration with PACS and hospital IT systems ensures efficient workflow and reporting. Government funding and insurance reimbursement policies support MRI adoption in urban and regional hospitals. Rising demand for advanced diagnostic capabilities reinforces MRI’s dominant position.

The ultrasound segment is expected to witness the fastest growth from 2026 to 2033, driven by advancements in portable and high-resolution systems for point-of-care diagnostics. Ultrasound’s non-invasive nature and absence of ionizing radiation make it ideal for repeated use in obstetrics, cardiology, and musculoskeletal applications. AI-enabled image analysis and 3D/4D imaging enhance diagnostic accuracy and clinical confidence. Rising demand for real-time imaging in interventional procedures accelerates adoption. Outpatient and specialty clinics increasingly invest in portable ultrasound units for convenience. Improved training and awareness further fuel growth, particularly in rural and underserved regions.

• By Technology

On the basis of technology, the market is segmented into 2D, 3D/4D, Intraoperative 2D/3D, and Others. The 3D/4D imaging segment dominated in 2025 due to its ability to provide detailed volumetric visualization for complex clinical assessments. Hospitals and advanced diagnostic centers use 3D/4D modalities for neurology, oncology, cardiology, and musculoskeletal imaging. Integration with PACS and electronic health records ensures efficient data management and collaboration across departments. Radiologists and surgeons rely on these systems for improved diagnostic confidence and treatment planning. Government investments in advanced imaging infrastructure support adoption. The maturity of 3D/4D technology and its broad clinical utility secure its dominant position.

Intraoperative 2D/3D imaging is expected to grow fastest from 2026 to 2033, supported by the increasing demand for real-time imaging during minimally invasive and image-guided surgeries. These systems enhance surgical precision and reduce complications in orthopedics, neurosurgery, and interventional procedures. Portable intraoperative units provide flexibility in operating theatres without extensive infrastructure changes. Hospitals and specialty surgical centers adopt these systems to improve outcomes and efficiency. Technological advancements such as low-dose imaging and AI-assisted guidance drive growth. Increasing awareness of benefits among surgeons accelerates uptake.

• By Application

On the basis of application, the market is segmented into diagnostics systems and interventional systems. Diagnostics systems dominated the market in 2025 as they are critical for disease detection, screening, and clinical evaluation across hospitals and diagnostic centers. Modalities such as X-ray, MRI, CT, and ultrasound form the backbone of diagnostic workflows. Integration with hospital IT and PACS ensures streamlined reporting and improved clinical decision-making. High utilization rates in emergency, inpatient, and outpatient care reinforce dominance. Government funding and preventive healthcare initiatives support extensive adoption. Reliable performance and clinician familiarity with diagnostic systems further solidify their position.

Interventional systems are expected to grow fastest from 2026 to 2033, due to increasing adoption of minimally invasive procedures requiring real-time imaging guidance. These systems support vascular interventions, biopsies, pain management, and targeted therapy. Hospitals and hybrid operating suites benefit from improved procedural accuracy and reduced recovery times. Technological innovations, including AI-assisted imaging and portable interventional units, boost growth. Rising prevalence of cardiovascular and oncological interventions accelerates demand. Reimbursement policies favoring image-guided procedures further drive adoption.

• By Modality

On the basis of modality, the market is segmented into Stationary System, Portable/Mobile System, and Point-of-Care (POC) System. Stationary systems dominated the market in 2025 due to their presence in major hospitals and high-volume diagnostic centers. These systems, including fixed MRI, CT, and X-ray units, offer superior imaging performance for complex diagnostics. Integration with enterprise imaging platforms enhances workflow efficiency. Hospitals prefer stationary systems for high throughput, multidisciplinary use, and long-term reliability. Government-funded facilities continue to invest heavily in stationary units. The stability, advanced features, and maintenance support make stationary systems indispensable.

Portable and mobile imaging systems are expected to grow fastest from 2026 to 2033, due to increasing demand for flexible imaging in emergency care, outpatient clinics, and rural regions. Portable X-ray, ultrasound, and CT units provide bedside diagnostics without major infrastructure changes. Technological advancements have improved image quality and connectivity. Smaller hospitals and specialty clinics can now access advanced imaging without high capital expenditure. Government initiatives to decentralize healthcare support adoption. Enhanced portability and patient convenience accelerate market growth.

• By Indication

On the basis of indication, the market is segmented into cardiology, pelvic and abdominal, oncology, mammography, gynecology, neurology, urology, musculoskeletal, dental, and others. Oncology dominated the market in 2025 as imaging is central to cancer detection, staging, treatment planning, and follow-up. MRI, CT, and PET/CT scans provide detailed tumor visualization for clinicians. Cancer prevalence and national screening programs drive consistent demand. Advanced imaging is integrated into oncology care pathways and research initiatives. High utilization in urban hospitals and specialized cancer centers reinforces dominance. AI-assisted imaging enhances detection accuracy and supports multidisciplinary treatment planning.

Cardiology is expected to grow fastest from 2026 to 2033, due to rising prevalence of cardiovascular diseases and expanding use of advanced cardiac imaging modalities such as cardiac MRI, CT angiography, and echocardiography. Early detection and non-invasive assessment improve patient outcomes. Clinics and outpatient cardiology centers increasingly invest in dedicated imaging solutions. Technological innovations, including AI-enhanced image interpretation and real-time monitoring, support adoption. Preventive care programs emphasizing early diagnosis accelerate growth. Growing patient awareness and demand for specialized cardiac diagnostics further fuel adoption.

• By End User

On the basis of end user, the market is segmented into hospitals, diagnostic centers, imaging centers, specialty clinics, ambulatory surgical centers, academic & research institutes, and others. Hospitals dominated the market in 2025 with the largest revenue share due to high patient volumes, comprehensive imaging infrastructure, and multidisciplinary diagnostic workflows. Tertiary and regional hospitals continuously invest in advanced modalities such as MRI, CT, and PET/CT. Integration with hospital IT systems and PACS enhances workflow efficiency. Government-funded hospitals benefit from capital expenditure programs. Skilled radiologists and clinical teams ensure high utilization. Hospitals remain central to imaging delivery, reinforcing their dominant position.

Diagnostic centers are expected to grow fastest from 2026 to 2033, as patients increasingly seek convenient, outpatient imaging services with reduced wait times. Private and standalone centers invest in high-resolution MRI, ultrasound, and CT systems. Partnerships with primary care providers increase patient inflow. Flexible scheduling and patient-centric services drive adoption. Digital platforms for bookings and results improve operational efficiency. Expansion in regional and urban areas accelerates market penetration.

• By Distribution Channel

On the basis of distribution channel, the market is segmented into direct tender, retail sales, and third-party distributor. Direct tender dominated the market in 2025 as hospitals and government health authorities procure imaging systems via formal bidding processes. Bulk purchasing ensures cost efficiency, standardized equipment, and long-term service agreements. Centralized procurement facilitates interoperability across facilities. Government budget cycles support scheduled tender processes. Institutional preference for comprehensive warranties and service packages favors direct tendering. High-value and complex imaging equipment typically follows this channel.

Third-party distributors are expected to grow fastest from 2026 to 2033, by serving smaller clinics, specialty centers, and emerging imaging providers. Distributors provide flexible purchasing options, financing, and after-sales support. Localized presence enables tailored solutions for diverse client needs. Growth in portable and mid-range imaging systems drives distributor adoption. Training and service packages enhance usability and reliability. Expansion into regional and rural markets accelerates third-party distribution growth.

New Zealand Medical Imaging Market Share

The New Zealand Medical Imaging industry is primarily led by well-established companies, including:

• Pacific Radiology (New Zealand)
• ISL Ltd (New Zealand)
• Electron Medical (New Zealand)
• Cass Medical (New Zealand)
• DPI Medical New Zealand Limited (New Zealand)
• Radiographic Supplies Ltd (New Zealand)
• CANON MEDICAL SYSTEMS CORPORATION (Japan)
• Compagnie Générale des Établissements Guerbet (France)
• Koninklijke Philips N.V. (Netherlands)
• Shimadzu Corporation (Japan)
• Fujifilm Sonosite, Inc. (U.S.)
• BD (U.S.)
• Medtronic plc (Ireland)
• Paragon Care Group Limited (Australia)
• Quantum Healthcare Limited (Australia)
• Carestream Health, Inc. (U.S.)
• Hologic, Inc. (U.S.)
• United Imaging Healthcare Co., Ltd (China)
• Cutera, Inc. (U.S.)

What are the Recent Developments in New Zealand Medical Imaging Market?

• In December 2025, Wellington Regional Hospital installed a new advanced SPECT‑CT scanner that combines nuclear medicine and CT imaging technologies, improving diagnostic precision and patient experience as part of broader imaging infrastructure upgrades
• In October 2025, the New Zealand Government announced a major nationwide upgrade of diagnostic imaging infrastructure with a NZ$108 million investment to deliver 32 new and replacement CT, MRI, and SPECT scanners across 14 hospitals, aimed at increasing national imaging capacity and access to faster, more accurate medical imaging services
• In October 2025, Kenepuru Hospital in Porirua commissioned a new state‑of‑the‑art photon‑counting CT (PCCT) scanner the second of its kind in New Zealand offering higher resolution and faster imaging that enhances diagnostic capabilities for cardiac and other conditions
• In August 2025, Mobile Imaging expanded PET‑CT access for public patients in New Zealand by enabling referrals at multiple sites (Palmerston North, Lower Hutt, and Dunedin), providing advanced hybrid PET‑CT scans closer to home and reducing travel burdens for cancer patients
• In March 2025, More than 10,000 additional MRI and CT scans per year became available in Hawke’s Bay following the completion of a substantial radiology upgrade at Hawke’s Bay Fallen Soldiers’ Memorial Hospital, doubling both MRI and CT capacity to meet local diagnostic demand

SKU-61562